AC
IRON icon

AXQ Capital’s Disc Medicine IRON Stock Holding History

AXQ Capital’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$441K Buy
+6,035
New +$415K 0.05% 517

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AXQ Capital's IRON Position: Q2 2026 in Review

AXQ Capital opened a new position in Disc Medicine (IRON) in Q2 2026: 6,035 shares worth $441K. The stake represents 0.05% of the portfolio and ranks #517 among its holdings.

215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • AXQ Capital held 6,035 shares of Disc Medicine worth $441K as of Q2 2026.
  • Disc Medicine was a new AXQ Capital position in Q2 2026.
  • Disc Medicine made up 0.05% of AXQ Capital's portfolio in Q2 2026, its #517 holding.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.